National bundle of care for children and young people with asthma published in England

28

Oct 2021

On September 23, 2021, NHS England and Improvement (NHSE/I) published the National bundle of care for children and young people (CYP) with asthma, which is phase one of a plan to support Integrated Care Systems (ICSs) in delivering high-quality asthma care.

The following documents are available:

  • "National bundle of care for children and young people with asthma" provides standards;
  • "National bundle of care for children and young people with asthma: integrated care system deliverables" - specific actions that ICSs should take;
  • "National bundle of care for children and young people with asthma: resource pack" - templates and forms.

The program sets out the blueprint of evidence-based interventions and will focus on improving each of the following components based on the patient pathway:

  • Environmental impacts (parental smoking, air pollution);
  • Accurate and early diagnosis (primary, secondary, and tertiary care);
  • Effective preventative medicine (self-management, primary, emergency (111), secondary care);
  • Managing exacerbations (self-management, apps/peakflow, primary, emergency (111), secondary care, PICU);
  • Severe asthma (service specification, new therapies, R&D).

Each component formed National working groups, chaired by prominent experts in that field, with membership spanning all regions of England, healthcare professionals, young people, carers, and other stakeholders. The program was overseen by an Asthma Oversight Group, with representatives from across health systems, National Bodies, Royal Colleges, and the third sector.

Two additional working groups (asthma competencies, training, and education needs; data and digital) were formed to support the development of the bundle.

A final and complete version of the National bundle of care will be published in Spring 2022.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

01

Mar 2022

On February 04, 2022, NHSX announced merging with NHS Digital into the new Transformation Directorate at NHS England. NHSX's mission will remain the same - to drive the digital transformation of the NHS and social care.

Read more

16

Feb 2022

On February 02, 2022, NHS England updated the 2021/22 National Genomic Test Directory for rare and inherited diseases, initially published in October 2021. No new codes were introduced. Amendments were made in 77 codes, including changing the test method, commissioning category, specialist group.

Read more

11

Feb 2022

A new multi-agency advisory service (MAAS) is currently under development by the National Institute of Health and Care Excellence (NICE). This new cross-regulatory service will be a “one-stop-shop” for support, information, and guidance on the regulation and evaluation of AI technologies. The launch of the new service is scheduled for summer 2022.

Read more